Cancer Genetics Liquid::Lung-cfDNA

Cancer Genetics has launched a new multi-gene liquid biopsy test for lung cancer, based on Thermo Fisher's Oncomine Lung Cell-Free DNA NGS assay. Run on the Ion S5 XL sequencing system, the test provides comprehensive coverage of 11 critical genes and over 150 key hotspots related to lung cancer and has a limit of detection of 0.05 percent.